- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02853279
Physical Activity and Intermittent Exercise Training for Cardiovascular and Cognitive Gain in Obese Women
The Effect of (i) Physical Activity and (ii) Continuous Versus Intermittent Exercise Training Upon Cardiovascular and Cognitive Function in Obese Women
Study Overview
Status
Intervention / Treatment
Detailed Description
The study will involve two stages (i) recruiting participants for a cross sectional analysis of the relationship between physical activity levels and cardiovascular and cognitive function, and (ii) a longer exercise training study in a subsample of these volunteers. 100 participants for stage 1 will visit the laboratory in the University on three occasions (within a three week period) to be assessed for anthropometric outcomes, body composition, exercise tolerance, cognitive function and arterial and cardiac health. Each visit will last for 60 - 90 minutes. Participants will then be provided with an accelerometer to wear for a period of one week in order to assess movement counts and sedentary behaviour. Stage 2 will include only those participants who are happy to continue into the exercise training phase. These participants will then be matched for age and BMI and then randomly (on matched pairs) allocated to one of two groups. Both groups will exercise three times per week for 12 weeks duration. Group 1 will exercise in a traditional manner undertaking continuous exercise, whilst the Group 2 will exercise at a heavy intensity but in short bursts (interval exercise). Both groups will complete the same amount of work but in two differing modes. Both groups will attend the laboratory twice per week for supervised exercise sessions and also perform one home based 30 minute brisk walk per week. All participants will be re-examined at 12 weeks.
Recruitment of participants
One hundred participants from a combination of (a) local advertisements and/or (b) those whose details are held on a research database (of previous volunteers indicating willingness to be contacted about future studies) will be sought to volunteer for this study. Participants will be contacted via email/telephone/letter to provide information regarding this study. All volunteers interested in participating will be contacted to provide general information during a preliminary telephone screening interview. This will be used to check main inclusion and exclusion criteria. The women who fit these criteria will be sent the participant information sheet to read carefully and if still interested invited to attend the first laboratory visit for a screening session. Participants have greater than 48 hours to assess the participant information sheet before they attend this first visit when, if eligible, they will be asked to provide written informed consent.
Laboratory Visits
Visit 1
During this visit the study and all procedures will be explained in detail to all participants, and written informed consent will be taken. A thorough medical history will be obtained and participants will be asked to complete a Recruitment Information Questionnaire (RIQ) to confirm all inclusion/ exclusion criteria. Participants will complete the National Adult Reading Test (NART) which estimates premorbid intelligence levels.
Participants will also complete a Physical Activity Readiness Questionnaire (PAR-Q) which will be reviewed to determine whether participants are fit to continue with the study. Simple measures of body weight, height and waist circumference will be taken. Participants will complete a practice version of the cognitive test battery to demonstrate the tests, ensure participants understand how to perform the tests correctly and assess compliance (effort).
Participants will complete a cycling test on a stationary bicycle under the supervision of the investigator and a medic.
Visit 2
The second visit will involve several measures of arterial health which requires participants to attend in a 12 hour fasted state. Blood vessel function will be assessed using a blood pressure cuff around the lower arm for a period of 5 minutes. Cardiac structure and function will be assessed using two-dimensional (2D) echocardiography. Vascular function will be assessed using ultrasound and applanation tonometry. All procedures are non-invasive. Percentages of body fat and muscle mass will be measured using bioimpedance.
A 60ml blood sample will be taken which will be used to asses endothelial progenitor cell number and function, insulin sensitivity, cholesterol levels and is part of the assessment for health of the arteries and vascular system.
Visit 3
On the third visit a cognitive function test will be completed, which requires participants to attend in a 12 hour fasted state.
Participants will perform a 45 minute battery of cognitive tests. Following the cognitive tests, participants will be asked to complete a cognitive test evaluation questionnaire to assess both subjective and objective cognition.
At the end of the third laboratory visit all participants will be provided with an ActiHeart accelerometer (Actigraph, Pensacola, USA) to wear for a period of one week in order to assess movement counts and sedentary behaviour. At the end of the seven days the accelerometer is given back to or collected by the team and the data downloaded.
The three baseline laboratory visits plus the seven days using the ActiHeart accelerometer all come under stage 1 of the study. Participants will be asked to continue into the exercise training stage (stage 2), and willing volunteers will move through to the second stage of the experiment. All measures will be repeated at 12 weeks (78 hours to 5 days following cessation of the last exercise training session).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
West Yorkshire
-
Leeds, West Yorkshire, United Kingdom, LS2 9JT
- Centre for Sports and Exercise Sciences, University of Leeds
-
Leeds, West Yorkshire, United Kingdom, LS2 9JT
- Human Appetite Research Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sedentary women (exercise ≤2 day per week)
- Pre-menopausal (age 35- 50 years)
- BMI of ≥30 kg/m2
- Able to give informed consent .
- Non-smokers
- Vision sufficiently good to complete the cognitive testing (using glasses and/or lenses).
Exclusion Criteria:
- Male
- BMI < 30 kg/m2
- Clinically diagnosed with type 1 or type 2 diabetes
- Resting/exercise ECG indicating significant ischemia, recent myocardial infarction or other acute cardiac event or other exercise related ECG abnormalities.
- Unstable angina.
- Uncontrolled hypertension.
- Uncontrolled cardiac dysrhythmias
- The use of antidepressant, antianxiety, or thyroid medication.
- Dementia
- Neurological disorder
- Previous stroke or Transient Ischaemic Attack (TIA)
- Musculoskeletal impairment or injury
- Medication that has a direct effect on the brain and is likely to influence cognitive function.
- Current smokers or those who have given up in the previous 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Interval exercise training
Supervised exercise training undertaking interval exercise twice per week for 30 min each visit over 12 weeks.
|
Interval exercise sessions (INT) involving work:recovery ratios of 40 s at 70% delta work-rate followed by 80 s active recovery at 20 W. 70% delta (∆) is 70% of the difference between work rate peak (WRpeak) and work rate at the lactate threshold (WRLT) calculated as: 70%∆ =0.7(〖WR〗_peak- 〖WR〗_LT )+ 〖WR〗_LT Where WR is work rate, LT is lactate threshold) Each session was for 30 min and this was undertaken twice per week for 12 weeks. One home based exercise session was incorporated per week. |
Active Comparator: Continuous exercise training
Supervised exercise training undertaking continuous exercise twice per week for 30 min each visit over 12 weeks.
|
Exercise sessions involved cycling at 20%∆ work-rate peak for the duration of the session.
This work-rate was chosen so that all participants in the group would be exercising in the heavy-intensity domain.
To enable participants in the CON exercise group to complete the same amount of work (kJ) as the participants in the INT exercise group, the amount of work that would be completed if the CON participants completed an INT exercise session was calculated.
Participants exercised for 26 min (varying to match interval group) twice per week for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal oxygen uptake (CPX)
Time Frame: Change at 12 weeks
|
Maximal oxygen uptake assessed during a ramp incremental cycle ergometry test.
|
Change at 12 weeks
|
Flow mediated dilatation
Time Frame: Change at 12 weeks
|
Percentage change in brachial artery diameter following cuff occlusion using doppler ultrasound.
|
Change at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lactate threshold
Time Frame: Baseline and 12 weeks
|
Lactate threshold estimated from pulmonary gas exchange criteria
|
Baseline and 12 weeks
|
Blood borne (plasma) inflammatory marker
Time Frame: Baseline and 12 weeks
|
high sensitivity C reactive protein
|
Baseline and 12 weeks
|
Work rate peak
Time Frame: Baseline and 12 weeks
|
The peak work rate achieved during the maximal oxygen uptake assessment
|
Baseline and 12 weeks
|
Circulating angiogenic cell number
Time Frame: Baseline and 12 weeks
|
CD34+CD45dimKDR+ via Flow cytometry
|
Baseline and 12 weeks
|
Circulating cytokines
Time Frame: Baseline and 12 weeks
|
vascular endothelial growth factor
|
Baseline and 12 weeks
|
Circulating cytokines
Time Frame: Baseline and 12 weeks
|
stromal derived factor 1
|
Baseline and 12 weeks
|
Arterial stiffness
Time Frame: Baseline and 12 weeks
|
Doppler assessed and Sphygmacor assessed changes in stiffness via pulse wave velocity
|
Baseline and 12 weeks
|
Cognitive function (Visual spatial learning scale)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Cognitive function (Tower of Hanoi)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Cognitive function (Grooved peg board)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Cognitive function (Visual verbal learning scale)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Cognitive function (Bakan test))
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Cognitive function (Corsi block tapping)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Physical activity level
Time Frame: Baseline and 12 weeks
|
Accelerometer assessed physical activity (Actiheart) worn on the hip
|
Baseline and 12 weeks
|
Blood pressure
Time Frame: Baseline and 12 weeks
|
Blood pressure
|
Baseline and 12 weeks
|
Body composition
Time Frame: Baseline and 12 weeks
|
Bioelectrical impedence analysis (BIOSTAT) assessment of fat mass
|
Baseline and 12 weeks
|
Cardiac function (echocardiography)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Cardiac structure (echocardiography)
Time Frame: Baseline and 12 weeks
|
Baseline and 12 weeks
|
|
Adhesion of cultured angiogenic cells to vascular smooth muscle cells
Time Frame: Baseline and 12 weeks
|
Number of cells adhering
|
Baseline and 12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karen M Birch, PhD, University of Leeds
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BIOSCI 10-021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Interval exercise training
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
St. Olavs HospitalNorwegian University of Science and TechnologyCompletedTachycardia, Ventricular | Defibrillators, ImplantableNorway
-
Rigshospitalet, DenmarkCompleted
-
Assaf-Harofeh Medical CenterCompletedMyocardial Infarction | Coronary Artery DiseaseIsrael
-
Instituto de Investigación Sanitaria de la Fundación...Completed
-
Cairo UniversityCompletedArterial StiffnessEgypt
-
Cairo UniversityRecruitingMultiple SclerosisEgypt
-
Poznan University of Physical EducationPoznan University of Medical SciencesCompletedHypertension | Obesity | Dyslipidemias | Type 2 Diabetes | Endothelial DysfunctionPoland
-
Georgia State UniversityWithdrawnAnalgesia | Pain, Acute | Exercise Training | Aerobic Exercise | Pain, NeuropathicUnited States